CÉSAR HERNÁNDEZ GARCÍA-rekin lankidetzan egindako argitalpenak (33)

2013

  1. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855

2009

  1. Treatment of refractory posterior uveitis with infliximab: A 7-year follow-up study

    Scandinavian Journal of Rheumatology, Vol. 38, Núm. 1, pp. 58-62

2008

  1. Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life

    Journal of Rheumatology, Vol. 35, Núm. 1, pp. 159-165

  2. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain

    Scandinavian Journal of Rheumatology, Vol. 37, Núm. 6, pp. 419-426

  3. Observed and expected frequency of comorbid chronic diseases in rheumatic patients

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 3, pp. 418-421

  4. Prognostic factors in short-term disability due to musculoskeletal disorders

    Arthritis Care and Research, Vol. 59, Núm. 4, pp. 489-496

2007

  1. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis

    Arthritis and Rheumatism, Vol. 56, Núm. 8, pp. 2789-2797

  2. Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 3, Núm. 6, pp. 245-250

  3. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction

    Osteoarthritis and Cartilage, Vol. 15, Núm. 4, pp. 475-478

  4. Musculoskeletal work disability for clinicians: Time course and effectiveness of a specialized intervention program by diagnosis

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 335-342

  5. Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain

    Journal of Rheumatology, Vol. 34, Núm. 7, pp. 1485-1490

2005

  1. A health system program to reduce work disability related to musculoskeletal disorders

    Annals of Internal Medicine, Vol. 143, Núm. 6

2003

  1. Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study

    Arthritis Care and Research, Vol. 49, Núm. 1, pp. 64-70

  2. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: Comment on the article by Hoffman et al [1]

    Arthritis and Rheumatism

  3. Incidencia y características de la tuberculosis en pacientes con enfermedades reumáticas autoinmunes

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 178-182

2001

  1. Combined treatment of giant-cell arteritis with methotrexate and prednisone: A randomized, double-blind, placebo-controlled trial

    Annals of Internal Medicine, Vol. 134, Núm. 2, pp. 106-114

  2. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 28, Núm. 6, pp. 1222-1228

  3. Methotrexate in giant-cell arteritis [2] (multiple letters)

    Annals of Internal Medicine

2000

  1. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 27, Núm. 10, pp. 2323-2328

  2. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis

    Journal of Rheumatology, Vol. 27, Núm. 9, pp. 2198-2202